Chemotherapeutic options in chronic lymphocytic leukemia: A meta- analysis of the randomized trials

Journal of the National Cancer Institute

Volumn 91, Issue 10, 1999, Pages 861-868

  Richards, S ^a   Clarke, M ^a   Wheatley, K ^a   Peto, R ^a  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONSERVATIVE TREATMENT; CYTOTOXICITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELIABILITY; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; PREDNISONE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0033583824     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Catovsky D, Murphy RL. Key issues in the treatment of chronic lymphocytic leukaemia. Eur J Cancer 1995;31A:2146-54.
2. Rozman C, Montserrat E. Chronic lymphocytic leukemia [published erratum appears in N Engl J Med 1995;333:1515]. N Engl J Med 1995;333: 1052-7.
3. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, et al. National Cancer Institute - sponsored Working Group Guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7.
4. Dighiero G, Binet JL. Chronic lymphocytic leukemia. Hematol Cell Ther 1996;38(Suppl 2):S41-61.
5. French Cooperative Group on Chronic Lymphocytic Leukaemia. Effectiveness of "CHOP" regimen in advanced untreated chronic lymphocytic leukemia. Lancet 1986;1:1346-9.
6. Binet JL, Anquier A, Dighiero G, Chastang C, Pignet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
7. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-34.
8. Brugiatelli M, Jaksic B, Planinc-Peraica A, Kusec R, Ostojic S, Callea V, et al. Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trial. Eur J Haematol 1995;55:158-63.
9. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy, 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15.
10. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J (Clin Res Ed) 1988; 296:320-31.
11. Shustik C, Mick R, Silver R, Sawitsky A, Rai K, Shapiro L. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation. Hematol Oncol 1988;6:7-12.
12. Montserrat E, Alcala A, Parody R, Domingo A, Garcia-Conde J, Bueno J, et al. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone. Cancer 1985;56:2369-75.
13. French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. Blood 1990;75:1414-21.
14. Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, et al. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 1998;338: 1506-14.
15. Rai KR, Peterson B, Elias L, Shepherd L, Hines J. Nelson D, et al. A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C, and ECOG Inter-Group Study [abstract]. Blood 1996;88: 141a.
16. Binet JL, Chastang C, Chevret S, Dighiero G, Maloum K, Travada P. Comparison of fludarabine, CAP and CHOP in advanced previously untreated chronic lymphocytic leukemia [abstract]. Blood 1993;82:140a.
17. Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, et al. Multicentre prospective randomised trial of fludarabine versus cyclophos-phamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet 1996;347:1432-8.
18. Catovsky D, Richards S, Fooks J, Hamblin TJ. CLL trials in the United Kingdom. MRC CLL trials 1, 2 and 3. Leuk Lymphoma 1991; Suppl 4: 105-12.
19. Spanish Cooperative Group Pethema. Treatment of chronic lymphocytic leukemia: a preliminary report of Spanish (Pethema) trials. Leuk Lymphoma 1991;Suppl 4:89-91.
20. Han T, Ezdinli EZ, Shimaoka K, Desai DV. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer 1973;31:502-8.
21. French Cooperative Group on Chronic Lymphocytic Leukemia. A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. Blood 1990;75:1422-5.
22. Raphael B, Andersen JW, Silber R, Oken M, Moore D, Bennett J, et al. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomised clinical trial. J Clin Oncol 1991;9:770-6.
23. Kimby E, Mellstedt H. Chlorambucil/prednisolone versus CHOP in symptomatic chronic lymphocytic leukemias of B-cell type. Leuk Lymphoma 1991;Suppl 4:93-6.
24. Hansen MM, Andersen E, Birgens H, Christensen BE, Christensen TG, Geisler C, et al. CHOP versus chlorambucil + prednisolone in chronic lymphocytic leukemia. Leuk Lymphoma 1991;Suppl 4:97-100.
25. The French Cooperative Group on Chronic Lymphocytic Leukemia. Therapeutic results from the trials managed by the French Cooperative Group on Chronic Lymphocytic Leukemia. Leuk Lymphoma 1991;Suppl 4:83-8.
26. Jaksic B, Brugiatelli M, Krc I, Losonczi H, Holowiecki J, Planinc-Peraica A, et al. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna. Cancer 1997;79:2107-14.
27. Catovsky D, Hamblin T, Richards S. Preliminary results of the UK MRC trial in chronic lymphocytic leukaemia - CLL3. Abstract O-114 in: Proceedings of the 27th Congress of the International Society of Haematology (ISH-EHA). Br J Haemaol 1998;102:278.